Xiaowu Dong

4.6k total citations
181 papers, 3.6k citations indexed

About

Xiaowu Dong is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Xiaowu Dong has authored 181 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 56 papers in Oncology and 43 papers in Organic Chemistry. Recurrent topics in Xiaowu Dong's work include Protein Degradation and Inhibitors (33 papers), Computational Drug Discovery Methods (26 papers) and Ubiquitin and proteasome pathways (22 papers). Xiaowu Dong is often cited by papers focused on Protein Degradation and Inhibitors (33 papers), Computational Drug Discovery Methods (26 papers) and Ubiquitin and proteasome pathways (22 papers). Xiaowu Dong collaborates with scholars based in China, Czechia and Macao. Xiaowu Dong's co-authors include Yongzhou Hu, Jinxin Che, Qiaojun He, Tao Liu, Bo Yang, Xin‐Yuan Liu, Jinhao Zhao, Jingli Cheng, Yong Yang and Chi‐Ming Che and has published in prestigious journals such as Nucleic Acids Research, Advanced Materials and Nature Communications.

In The Last Decade

Xiaowu Dong

169 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaowu Dong China 32 1.6k 994 562 349 329 181 3.6k
Lei Shi China 29 1.3k 0.8× 1.0k 1.1× 826 1.5× 293 0.8× 339 1.0× 141 3.3k
Allan M. Jordan United Kingdom 27 2.5k 1.6× 2.7k 2.7× 515 0.9× 500 1.4× 157 0.5× 61 4.9k
Wei Lü China 37 2.2k 1.4× 1.3k 1.3× 516 0.9× 139 0.4× 462 1.4× 239 4.6k
Simon J. F. Macdonald United Kingdom 34 1.7k 1.1× 2.3k 2.4× 314 0.6× 385 1.1× 239 0.7× 111 4.5k
Jóhannes Reynisson New Zealand 33 1.8k 1.1× 1.7k 1.7× 820 1.5× 147 0.4× 286 0.9× 154 3.7k
Yongzhou Hu China 38 2.0k 1.2× 2.1k 2.1× 502 0.9× 328 0.9× 574 1.7× 244 5.0k
Jianxin Duan United States 24 1.2k 0.7× 662 0.7× 289 0.5× 142 0.4× 228 0.7× 54 2.3k
Nuno M. F. S. A. Cerqueira Portugal 30 1.6k 1.0× 492 0.5× 393 0.7× 338 1.0× 396 1.2× 93 2.9k
Jing Ai China 30 1.2k 0.8× 845 0.9× 415 0.7× 528 1.5× 464 1.4× 128 2.8k
Patric J. Jansson Australia 42 2.6k 1.6× 981 1.0× 2.4k 4.2× 417 1.2× 320 1.0× 85 5.5k

Countries citing papers authored by Xiaowu Dong

Since Specialization
Citations

This map shows the geographic impact of Xiaowu Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowu Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowu Dong more than expected).

Fields of papers citing papers by Xiaowu Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowu Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowu Dong. The network helps show where Xiaowu Dong may publish in the future.

Co-authorship network of co-authors of Xiaowu Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowu Dong. A scholar is included among the top collaborators of Xiaowu Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowu Dong. Xiaowu Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Lixin, Xiao-Li Zheng, Yu Cao, et al.. (2025). Development of novel epoxyketone macrocyclic peptidyl proteasome inhibitors through OPA-mediated one-step cyclization of unprotected peptides. Bioorganic Chemistry. 156. 108180–108180.
2.
Guo, Yu, Jinxin Che, & Xiaowu Dong. (2025). TransTACs: Transforming antibodies into targeted protein degraders. Acta Pharmaceutica Sinica B. 15(2). 1186–1188. 1 indexed citations
3.
Che, Jinxin, et al.. (2025). Recent Advances in Peptide Linkers for Antibody-Drug Conjugates. Journal of Medicinal Chemistry. 68(19). 19871–19892. 3 indexed citations
4.
Che, Zhaodi, Mingxiang Cai, Xiaowu Dong, et al.. (2025). Angiotensinogen inhibition concurrently mitigates alcohol-associated hepatic and muscle injury. Metabolism. 169. 156275–156275. 1 indexed citations
5.
Lu, Yang, Peipei Wang, Haifeng Chen, et al.. (2024). Discovery of potent small molecule ubiquitin-specific protease 10 inhibitors with anti-hepatocellular carcinoma activity through regulating YAP expression. European Journal of Medicinal Chemistry. 272. 116468–116468. 9 indexed citations
6.
Wu, Mingfei, Wei Wang, Tao Liu, et al.. (2024). Discovery of a potent CDKs/FLT3 PROTAC with enhanced differentiation and proliferation inhibition for AML. European Journal of Medicinal Chemistry. 275. 116539–116539. 5 indexed citations
7.
Lu, Yan, et al.. (2024). Combining AI and traditional screening for discovery of a potent ROCK2 inhibitor against lymphoma. Journal of Molecular Structure. 1303. 137394–137394.
8.
Pan, Youlu, Peipei Wang, Jinxin Che, et al.. (2024). Discovery of N-Benzylpiperidinol derivatives as USP7 inhibitors against Hematology. Bioorganic Chemistry. 153. 107807–107807.
9.
Yu, Qian, Mengna Li, Lixin Gao, et al.. (2024). DiPTAC: A degradation platform via directly targeting proteasome. Acta Pharmaceutica Sinica B. 15(1). 661–664. 2 indexed citations
10.
Yang, Lu, Yaping Xu, Yuxin Zhuang, et al.. (2024). Discovery of New Phenyltetrazolium Derivatives as Ferroptosis Inhibitors for Treating Ischemic Stroke: An Example Development from Free Radical Scavengers. Journal of Medicinal Chemistry. 67(14). 11712–11731. 7 indexed citations
11.
Guan, Xiaoqing, Yichao Wang, Wen-Kai Yu, et al.. (2024). Blocking Ubiquitin‐Specific Protease 7 Induces Ferroptosis in Gastric Cancer via Targeting Stearoyl‐CoA Desaturase. Advanced Science. 11(18). e2307899–e2307899. 39 indexed citations
12.
Gao, Jian, et al.. (2024). EvaluationMaster: A GUI Tool for Structure-Based Virtual Screening Evaluation Analysis and Decision-Making Support. Journal of Chemical Information and Modeling. 65(1). 7–14. 2 indexed citations
13.
Yao, Yuejun, Mingfei Wu, Yanfang Wang, et al.. (2024). An Oral PROTAC Targeting HPK1 Degradation Potentiates Anti‐Solid Tumor Immunity. Advanced Materials. 37(3). e2411454–e2411454. 5 indexed citations
14.
Wu, Mingfei, Yanhong Wang, Jingyu Zhang, et al.. (2023). Discovery of a potent and selective PARP1 degrader promoting cell cycle arrest via intercepting CDC25C-CDK1 axis for treating triple-negative breast cancer. Bioorganic Chemistry. 142. 106952–106952. 14 indexed citations
15.
Zhong, Yigang, et al.. (2023). A Microenvironment-responsive small-molecule probe and application in quick acute myocardial infarction imaging. Talanta. 270. 125571–125571. 3 indexed citations
16.
Sun, Xiuna, Zhen Chen, Yi Song, et al.. (2023). ADCdb: the database of antibody–drug conjugates. Nucleic Acids Research. 52(D1). D1097–D1109. 41 indexed citations
17.
Dong, Xiaowu, et al.. (2023). Stochastic Stabilization of Dual-Layer Rumor Propagation Model with Multiple Channels and Rumor-Detection Mechanism. Entropy. 25(8). 1192–1192. 2 indexed citations
18.
Zhu, Hong, Fangjie Yan, Tao Yuan, et al.. (2020). USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ. Cancer Research. 80(11). 2204–2216. 133 indexed citations
19.
Wei, Jun, et al.. (2018). Visible-light-mediated radical arylthiodifluoromethylation of isocyanides with fluorinated 2-pyridyl sulfones. Organic Chemistry Frontiers. 5(17). 2568–2572. 26 indexed citations
20.
Zhang, Chong, Tianyu Cai, Hong Zhu, et al.. (2011). Synergistic Antitumor Activity of Gemcitabine and ABT-737 In Vitro and In Vivo through Disrupting the Interaction of USP9X and Mcl-1. Molecular Cancer Therapeutics. 10(7). 1264–1275. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lei Shi Breakdown of academic impact, for papers by Allan M. Jordan Breakdown of academic impact, for papers by Wei Lü Breakdown of academic impact, for papers by Simon J. F. Macdonald Breakdown of academic impact, for papers by Jóhannes Reynisson Breakdown of academic impact, for papers by Yongzhou Hu Breakdown of academic impact, for papers by Jianxin Duan Breakdown of academic impact, for papers by Nuno M. F. S. A. Cerqueira Breakdown of academic impact, for papers by Jing Ai Breakdown of academic impact, for papers by Patric J. Jansson
Rankless by CCL
2026